Second Affiliated Hospital of Shantou University Medical College
9
5
6
2
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 9 trials
100.0%
+13.5% vs industry average
0%
0 trials in Phase 3/4
0%
0 of 2 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (9)
Tricuspid RegurgitAtion rIsk modeL Study (TRAIL Study)
Role: collaborator
FFR Versus IVUS with Angiography-Derived FFR for Clinical Outcomes in Patients with Coronary Artery Disease
Role: collaborator
Thrombus Aspiration in STEMI Patients With High Thrombus Burden
Role: collaborator
Enhanced External Counter Pulsation on Afterload Mismatch Rate in Post-TEER (PAMPER)
Role: collaborator
Angiography-Derived FFR And IVUS for Clinical Outcomes in Patients With Coronary Artery Disease
Role: collaborator
Routine Angiography Follow-Up After Percutaneous Coronary Intervention in High-Risk Patients
Role: collaborator
Aortic Valve Diseases RISk facTOr assessmenT and Prognosis modeL Construction
Role: collaborator
Birth Weight-discordance in Twins Pregnancy: a Multicenter Retrospective Study
Role: collaborator
Post-Marketing Surveillance of the Cinepazide Maleate Injection: a Real World Study
Role: collaborator
All 9 trials loaded